Καννα ℞++: Naturopathic Antidepressant
Καννα ℞++ is an FDA-approved medication for depression. Καννα contains medical-grade phytocannabinoids, linalools, and polyphenols that aid neurogenesis and naturally increase the production of dopamine in the body. Depression is a symptom of physical brain damage. Καννα prevents catastrophic neurodegenerative alterations by promoting neurogenesis.
Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis leads to prolonged hypercortisolemia and neurodegenerative alterations in several brain areas. Stress-induced neurotoxicity causes volumetric changes in the brain that increase HPA axis activity. Oxidative stress from viral infections and cancers increases glucocorticoids and induces neurotoxicity/neuronal loss in the hippocampus.
The endocannabinoid system comprises cannabinoid receptors (CB1 and CB2). The CB1 receptor regulates most central effects including mood. CB2 receptors in dopaminergic neurons influence psychomotor behaviors, anxiety, depression, and pain sensations. Καννα significantly increases blood flow in the hippocampus and activates GPCRs within the brain, specific to CB1 and CB2 receptors.
Καννα ℞++ increases synaptic plasticity and long-term hippocampal potentiation, improving learning and memory. Polyphenols in Καννα reduce inflammation and improve integrity of the blood-brain barrier (BBB), protecting the brain from injury.
Καννα ℞++ VS. Parkinson's
Καννα ℞++ reduces Aβ aggregation and reverses Aβ-induced memory loss in Alzheimer's patients. Καννα ℞++ alleviates neurodegeneration by reducing inflammation and ROS production.
Καννα ℞++ VS. Alzheimer's disease
Καννα ℞++ helps with the motor symptoms of Parkinson's disease by attenuating MPP+-induced neurite retraction.
Καννα ℞++ VS. Carpal tunnel syndrome
Καννα ℞++ protects neurons by reducing ROS levels in patients with carpal tunnel syndrome.
Καννα ℞++ VS. Global ischemia
Καννα ℞++ ameliorates neurological, motor, and cognitive impairments following global ischemia.